OCT 20, 2017 5:44 AM PDT

Rare Lymphoma Linked to Textured Breast Implants

WRITTEN BY: Xuan Pham

Image credit: Pixabay.com

According to a new review, cancer associated with breast implants is increasing, and researchers aren’t sure why.

The review, published in the journal JAMA Surgery, estimates that as much as 1 in 4,000 women with breast implants are diagnosed with a rare form of non-Hodgkin’s lymphoma, known as anaplastic large cell lymphoma (ALCL). Because of its association to breast implants, the condition is more specifically known as breast implant-associated ALCL (BIA-ALCL).

"We're seeing that this cancer is likely very underreported, and as more information on this type of cancer comes to light, the number of cases is likely to increase in the coming years," said Dr. Dino Ravnic, an assistant professor of surgery at the Pennsylvania State University College of Medicine, and the study’s senior author.

Ravnic and colleagues analyzed data from 115 studies over a 20-year period, from August 1997 to January 2017, that had ties with ALCL. In this time span, 93 cases of ALCL were confirmed. The diagnosis typically came about 10 years after the breast implant procedure. And nearly all of the cases of ALCL were associated with textured implants – those with a pebbly surface designed to minimize shifting post-surgery.

Interestingly, cases of ALCL did not seem to surface before the introduction of textured implants, suggesting a strong causal relationship between the type of implants and the occurrence of the lymphoma. “All manufacturers of textured implants have had cases linked to this type of [cancer], and we haven't seen cases linked to smooth implants," said Ravnic.

The current study comes on the heels of an announcement by the Food and Drug Administration earlier this year, which formally acknowledged the link between breast implants and ALCL. Moreover, the announcement reported a strong rise in ALCL occurrence. Since February 1 of this year, 359 cases of such cancer have been reported, including 9 deaths. This is almost four times the number of cases identified by Ravnic’s study, which analyzed data over a 20-year period.

Importantly, the FDA makes a clear distinction that the deaths were not caused by breast cancer. Rather, the malignant cells can be found in the scar tissues surrounding the breast implant.

"All of the information to date suggests that women with breast implants have a very low but increased risk of developing ALCL compared to women who do not have breast implants," wrote the FDA.

Fortunately, the cancer seems to be rare and not commonly fatal. The FDA suggests that removing the diseased tissue and implants is sufficient for most affected women, although some do require extended cancer treatments. Further, they note that women with implants who don’t show symptoms – lumps, pain, swelling of the breast area – are likely at low risk for the cancer.

Additional sources: Live Science

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
SEP 29, 2020
Cancer
Gut microbiome influences oral therapy for prostate cancer treatment
SEP 29, 2020
Gut microbiome influences oral therapy for prostate cancer treatment
Research from a team of scientists at Lawson Health Research Institute and Western University suggests that bacteria in ...
OCT 05, 2020
Health & Medicine
Cannabis Chemotherapy Trial Shows Encouraging Phase II Results
OCT 05, 2020
Cannabis Chemotherapy Trial Shows Encouraging Phase II Results
Even with the best anti-nausea medications one in three patients receiving chemotherapy experiences vomiting, and about ...
NOV 16, 2020
Cancer
Fingerprinting Ginger Extracts and Testing Their Anti-Cancer Abilities
NOV 16, 2020
Fingerprinting Ginger Extracts and Testing Their Anti-Cancer Abilities
Modern medicine relies on careful study and isolation of compounds or proteins, but many studies point to natural herbal ...
NOV 24, 2020
Clinical & Molecular DX
Young Inventor Creates Award-winning At-home Cancer Diagnostic
NOV 24, 2020
Young Inventor Creates Award-winning At-home Cancer Diagnostic
Getting a breast cancer diagnosis often means having to endure multiple tests, including some painful and invasive proce ...
NOV 26, 2020
Clinical & Molecular DX
Routine Diagnostic Tests Linked to a 59 Percent Increase in Testicular Cancer Risk
NOV 26, 2020
Routine Diagnostic Tests Linked to a 59 Percent Increase in Testicular Cancer Risk
New research has revealed that exposure to radiation from diagnostic procedures such as X-rays could contribute to an el ...
NOV 23, 2020
Cancer
Where are the geographic hotspots of high mortality rates for women with colorectal cancer?
NOV 23, 2020
Where are the geographic hotspots of high mortality rates for women with colorectal cancer?
A study published in Clinical and Translational Gastroenterology highlights the risk disparities in death rates fro ...
Loading Comments...